|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of caner in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Piazuelo MB and Correa P: Gastric cancer:
overview. Colomb Med (Cali). 44:192–201. 2013.PubMed/NCBI
|
|
3
|
Herrero R, Park JY and Forman D: The fight
against gastric cancer-the IARC Working Group report. Best Pract
Res Clin Gastroenterol. 28:1107–1114. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamamoto M, Rashid OM and Wong J: Surgical
management of gastric cancer: The East vs. West perspective. J
Gastrointest Oncol. 6:79–88. 2015.PubMed/NCBI
|
|
5
|
Gravalos C and Jimeno A: HER2 in gastric
cancer: A new prognostic factor and a novel therapeutic target. Ann
Oncol. 19:1523–1529. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qiu MZ, Li Q, Wang ZQ, Liu TS, Liu Q, Wei
XL, Jin Y, Wang DS, Ren C, Bai L, et al: HER2-positive patients
receiving trastuzumab treatment have a comparable prognosis with
HER2-negative advanced gastric cancer patients: A prospective
cohort observation. Int J Cancer. 134:2468–2477. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fuchs CS, Tomasek J, Yong CJ, Dumitru F,
Passalacqua R, Goswami C, Safran H, Santos LV, Aprile G, Ferry DR,
et al: Ramucirumab monotherapy for previously treated advanced
gastric or gastro-oesophageal junction adenocarcinoma (REGARD): An
international, randomised, multicentre, placebo-controlled, phase 3
trial. Lancet. 383:31–39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamada Y, Boku N, Nishina T, Yamaguchi K,
Denda T, Tsuji A, Hamamoto Y, Konishi K, Tsuji Y, Amagai K, et al:
Impact of excision repair cross complementing gene 1 (ERCC1) on the
outcomes of patients with advanced gastric cancer: Correlative
study in Japan Clinical Oncology Group Trial JCOG9912. Ann Oncol.
24:2560–2565. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsamandas AC, Kardamakis D, Tsiamalos P,
Liava A, Tzelepi V, Vassiliou V, Petsas T, Vagenas K, Zolota V and
Scopa CD: The potential role of Bcl-2 expression, apoptosis and
cell proliferation (Ki-67 expression) in cases of gastric carcinoma
and correlation with classic prognostic factors and patient
outcome. Anticancer Res. 29:703–709. 2009.PubMed/NCBI
|
|
10
|
Rasmussen AH, Rasmussen HB and
Silahtaroglu A: The DLGAP family: Neuronal expression, function and
role in brain disorders. Mol Brain. 10:432017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim E, Naisbitt S, Hsueh YP, Rao A,
Rothschild A, Craig AM and Sheng M: GKAP, a novel synaptic protein
that interacts with the guanylate Kinase-like domain of the
PSD-95/SAP90 family of channel clustering molecules. J Cell Biol.
136:669–678. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takeuchi M, Hata Y, Hirao K, Toyoda A,
Irie M and Takai Y: SAPAPs. A family of PSD-95/SAP90-associated
proteins localized at postsynaptic density. J Biol Chem.
272:11943–11951. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Naisbitt S, Valtschanoff J, Allison DW,
Sala C, Kim E, Craig AM, Weinberg RJ and Sheng M: Interaction of
the postsynaptic density-95/guanylate kinase domain-associated
protein complex with a light chain of myosin-V and dynein. J
Neurosci. 20:4524–4534. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu H, Reissner C, Kuhlendahl S, Coblentz
B, Reuver S, Kindler S, Gundelfinger ED and Garner CC:
Intramolecular interactions regulate SAP97 binding to GKAP. EMBO J.
19:5740–5751. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sabio G, Arthur JS, Kuma Y, Peggie M, Carr
J, Murray-Tait V, Centeno F, Goedert M, Morrice NA and Cuenda A:
p38gamma regulates the localisation of SAP97 in the cytoskeleton by
modulating its interaction with GKAP. EMBO J. 24:1134–1145. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Manneville JB, Jehanno M and
Etienne-Manneville S: Dlg1 binds GKAP to control dynein association
with microtubules, centrosome positioning, and cell polarity. J
Cell Biol. 191:585–598. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Naisbitt S, Kim E, Weinberg RJ, Rao A,
Yang FC, Craig AM and Sheng M: Characterization of guanylate
kinase-associated protein, a postsynaptic density protein at
excitatory synapses that interacts directly with postsynaptic
density-95/synapse-associated protein 90. J Neurosci. 17:5687–5696.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tong J, Yang H, Eom SH, Chum C and Im YJ:
Structure of the GH1 domain of guanylate kinase-associated protein
from Rattus norvegicus. Biochem Biophys Res Commun. 452:130–135.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Naisbitt S, Kim E, Tu JC, Xiao B, Sala C,
Valtschanoff J, Weinberg RJ, Worley PF and Sheng M: Shank, a novel
family of postsynaptic density proteins that binds to the NMDA
receptor/PSD-95/GKAP complex and cortactin. Neuron. 23:569–582.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen L, El-Husseini A, Tomita S, Bredt DS
and Nicoll RA: Stargazin differentially controls the trafficking of
alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate and kainate
receptors. Mol Pharmacol. 64:703–706. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen L, Chetkovich DM, Petralia RS,
Sweeney NT, Kawasaki Y, Wenthold RJ, Bredt DS and Nicoll RA:
Stargazin regulates synaptic targeting of AMPA receptors by two
distinct mechanisms. Nature. 408:936–943. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bats C, Groc L and Choquet D: The
interaction between Stargazin and PSD-95 regulates AMPA receptor
surface trafficking. Neuron. 53:719–734. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Matsuda S, Kakegawa W, Budisantoso T,
Nomura T, Kohda K and Yuzaki M: Stargazin regulates AMPA receptor
trafficking through adaptor protein complexes during long-term
depression. Nat Commun Nat Res. 4:27592013. View Article : Google Scholar
|
|
24
|
Tu JC, Xiao B, Yuan JP, Lanahan AA,
Leoffert K, Li M, Linden DJ and Worley PF: Homer binds a novel
proline-rich motif and links group 1 metabotropic glutamate
receptors with IP3 receptors. Neuron. 21:717–726. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rio DC, Ares M Jr, Hannon GJ and Nilsen
TW: Purification of RNA using TRIzol (TRI reagent). Cold Spring
Harb Protoc. 2010:pdb.prot5439. 2010. View Article : Google Scholar
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–208. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Goodpaster T and Randolph-Habecker J: A
flexible mouse-on-mouse immunohistochemical staining technique
adaptable to biotin-free reagents, immunofluorescence and multiple
antibody staining. J Histochem Cytochem. 62:197–204. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ang TL and Fock KM: Clinical epidemiology
of gastric cancer. Singapore Med J. 55:621–628. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kajimoto Y, Shirakawa O, Lin XH, Hashimoto
T, Kitamura N, Murakami N, Takumi T and Maeda K: Synapse-associated
protein 90/postsynaptic density-95-associated protein (SAPAP) is
expressed differentially in phencyclidine-treated rats and is
increased in the nucleus accumbens of patients with schizophrenia.
Neuropsychopharmacology. 28:1831–1839. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pinto D, Pagnamenta AT, Klei L, Anney R,
Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS,
et al: Functional impact of global rare copy number variation in
autism spectrum disorders. Nature. 466:368–372. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Welch JM, Lu J, Rodriguiz RM, Trotta NC,
Peca J, Ding JD, Feliciano C, Chen M, Adams JP, Luo J, et al:
Cortico-striatal synaptic defects and OCD-like behaviours in
Sapap3-mutant mice. Nature. 448:894–900. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bienvenu OJ, Wang Y, Shugart YY, Welch JM,
Grados MA, Fyer AJ, Rauch SL, McCracken JT, Rasmussen SA, Murphy
DL, et al: Sapap3 and pathological grooming in humans: Results from
the OCD collaborative genetics study. Am J Med Genet B
Neuropsychiatr Genet. 150B:710–720. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ryu S, Oh S, Cho EY, Nam HJ, Yoo JH, Park
T, Joo YH, Kwon JS and Hong KS: Interaction between genetic
variants of DLGAP3 and SLC1A1 affecting the risk of atypical
antipsychotics-induced obsessive-compulsive symptoms. Am J Med
Genet B Neuropsychiatr Genet. 156B:949–959. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Minocherhomji S, Hansen C, Kim HG, Mang Y,
Bak M, Guldberg P, Papadopoulos N, Eiberg H, Doh GD, Møllgård K, et
al: Epigenetic remodelling and dysregulation of DLGAP4 is linked
with early onset cerebellar ataxia. Hum Mol Genet. 23:6163–6176.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Anaya J: OncoLnc: Linking TCGA survival
data to mRNAs, miRNAs, and lncRNAs. Peerj Comput Sci. 2:e672016.
View Article : Google Scholar
|
|
38
|
Szász AM, Lánczky A, Nagy Á, Förster S,
Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B:
Cross-validation of survival associated biomarkers in gastric
cancer using transcriptomic data of 1,065 patients. Oncotarget.
7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pathan M, Keerthikumar S, Chisanga D,
Alessandro R, Ang CS, Askenase P, Batagov AO, Benito-Martin A,
Camussi G, Clayton A, et al: A novel community driven software for
functional enrichment analysis of extracellular vesicles data. J
Extracell Vesicles. 6:13214552017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pathan M, Keerthikumar S, Ang CS, Gangoda
L, Quek CY, Williamson NA, Mouradov D, Sieber OM, Simpson RJ, Salim
A, et al: FunRich: An open access standalone functional
enrichmentand interaction network analysis tool. Proteomics.
15:2597–2601. 2015. View Article : Google Scholar : PubMed/NCBI
|
